XERSXeris Biopharma Holdings Inc
XERS
Xeris Biopharma Holdings Inc10,694
Mkt Cap
$1.09BVolume
554,239.0052W High
$10.0852W Low
$4.30PE Ratio
-830.67XERS Fundamentals
Price
$6.22Prev Close
$6.23Open
$6.2850D MA
$5.92Beta
1.26Avg. Volume
1.35MEPS (Annual)
$0.0032P/B
75.64Rev/Employee
$670,908.05$1,503.09
Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the firm's stock in a transaction on Friday, May 1st. The stock was sold at an average price of $6.23, for a total value of $103,835.41. Following the sale, the insider directly owned 1,193,173...
MarketBeat·5d ago
Xeris Biopharma (XERS) to Release Earnings on Thursday
Xeris Biopharma (NASDAQ:XERS) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-xeris-pharmaceuticals-inc-stock...
MarketBeat·6d ago
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) has earned an average rating of "Moderate Buy" from the seven research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy r...
MarketBeat·12d ago
Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of...
Business Wire·13d ago
Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL trimmed its stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 83.1% during the third quarter, according to its most recent filing with the Securities...
MarketBeat·19d ago
Apella Capital LLC Acquires 235,897 Shares of Xeris Biopharma Holdings, Inc. $XERS
Apella Capital LLC increased its holdings in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 2,359.0% during the fourth quarter, according to the company in its most recent...
MarketBeat·28d ago
Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the business's stock in a transaction on Wednesday, April 1st. The shares were sold at an...
MarketBeat·1mo ago
Xeris Biopharma (NASDAQ:XERS) Insider Sells $99,835.33 in Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the firm's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at...
MarketBeat·1mo ago
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on April 1, 2026, the Compensation Committee of Xeris Board of...
Business Wire·1mo ago
Xeris Biopharma (NASDAQ:XERS) Director James Aloysius Brady Sells 10,834 Shares
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) Director James Aloysius Brady sold 10,834 shares of the firm's stock in a transaction on Monday, March 30th. The shares were sold at an average price of $5.54, for a total value of $60,020.36. Following the completion of the sale, the...
MarketBeat·1mo ago
<
1
2
...
>